ABSTRACT
Autoimmune diseases have shown biased proportion in female population, existing clinical investigations of sex hormones in autoimmune populations have been relatively limited in terms of patient size and types of hormones investigated. In this study, we examined the relationship of sexual hormones and autoimmune antibodies in a large cohort of US women. This retrospective study sample included a total of 15319 female subjects’ medical information that were collected between December 2015 to May 2019 and tested in the Vibrant America Clinical Laboratory. The present serum sample was limited to female participants who had ever menstruated at the time of blood collection and completed the testing of the autoimmune antibodies and sex hormones. We focused on a total of 13 clinically significant autoantibodies including antinuclear antibody (ANA), 11 anti-extractable nuclear antigens (anti-ENAs), anti-cyclic citrullinated peptide 3 (anti-CCP3), and 11 female sex hormones. First, the prevalence of serological autoantibodies in a large set of adult female subjects divided by the menopause age was investigated. Next, the levels of sex hormones were compared in the seropositive autoimmune subjects and seronegative controls across the pre- and post-menopausal female groups. The presented study involving a large cohort of females showed no statistically different levels of sex hormones in seropositive autoimmune subjects and matched controls except for DHEA-s.
Strengths and limitations of this study
For the first time, a large cohort of female subjects (N=15319) and their levels of 13 autoantibodies and 11 sex hormones were evaluated.
When possible, we concluded major literatures in related topics and compared with the data reported in this study.
Data were derived from a single laboratory, and the study was retrospective, which could have caused bias.
Competing Interest Statement
The authors have read the journal's policy and the authors of this manuscript have the following competing interests: YY and QS are paid employees of Vibrant America LLC. KK, VJ, TW, KB, HK, JJR, are paid employees of Vibrant Sciences LLC. Vibrant Sciences or Vibrant America could benefit from increased testing based on the results. There are no patents, products in development, or marketed products to declare. This does not alter our adherence to the journal policies on sharing data and materials.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Western Institutional Review Board (WIRB)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Emails of Authors: Yuanyuan Yang: shirley{at}vibrant-america.com
Qi Song: qsong{at}vibrant-america.com
Karthik Krishna: karthik{at}vibrantsci.com
Vasanth Jayaraman: vasanth.jayaraman{at}vibrantsci.com
Tianhao Wang: tianhao.wang{at}vibrantsci.com
Kang Bei: kang{at}vibrantsci.com
Data Availability
All relevant data are within the paper. Any additional data will be available upon request from Vibrant Sciences LLC by sending an email to hari{at}vibrantsci.com.
